Investment Risk Analysis: UZMAH LTD

1. Risk Rating: HIGH

The company has moved into a net liabilities position (-£30) as of October 2025, representing a dramatic and sustained erosion of shareholder value from £12,310 in 2022 to negative equity within three years. Total assets have collapsed to just £687, and the company is now technically balance-sheet insolvent. While the scale of this micro-entity is small, the trajectory is deeply concerning.

2. Key Concerns

i. Capital Erosion and Technical Insolvency

Net assets have declined precipitously over three consecutive years: £12,310 (2022) → £7,833 (2023) → £427 (2024) → -£30 (2025). The company now has negative shareholders' funds, meaning total liabilities exceed total assets. While the deficit is small in absolute terms (£30), the trend is unambiguous and indicates the business is not self-sustaining.

ii. Collapsed Asset Base

Total assets have fallen from £15,129 (2022) to £687 (2025) — a 95% reduction. With current assets of only £687 against creditors of £237, working capital is technically positive (£450), but this is entirely offset by £480 in accruals and deferred income, pushing the company into a net liability position. The £480 accrual/deferred income figure is disproportionately large relative to the asset base and warrants scrutiny — it may represent an obligation to deliver services or an accrued expense the company may struggle to meet.

iii. Single-Director Concentration Risk

The company has a sole director, Uzmah Xxxxxxxname shown to subscribers, who also holds more than 75% of shares and voting rights. There is no separation of ownership and management, no board oversight, and no external audit. This structure concentrates all operational, financial, and governance risk in one individual. If the director becomes unable to work (notably in a health activities business where the sole employee is likely the director-practitioner), the company has no operational continuity.

3. Positive Indicators

• Filing Compliance: Accounts and confirmation statements are up to date with no overdue filings. The company maintains its regulatory obligations.
• Long Operating History: Incorporated in October 2014, the company has operated for over a decade, suggesting some degree of operational persistence.
• Low Creditor Exposure: Current liabilities are only £237, meaning immediate third-party creditor pressure is minimal. The company is not carrying significant trade debt.
• Active Status: The company remains actively registered and has not entered any formal insolvency procedure.

4. Due Diligence Notes

1. Source of Asset Decline: The accounts are filleted (micro-entity regime, FRS 105), so no profit and loss account has been filed at Companies House. It is impossible to determine from filed records whether the erosion reflects trading losses, director drawings/dividends, or asset write-downs. The P&L account should be requested directly from the company.

2. Nature of the £480 Accruals/Deferred Income: This figure is the single largest item on the balance sheet and is the reason the company is in a net liability position. Investigation is needed to determine whether this represents deferred income (an obligation to deliver future services to paying clients) or accrued expenses (unpaid costs). The distinction materially affects the solvency assessment.

3. Going Concern Assessment: Micro-entity accounts are not required to include a directors' report or detailed going concern narrative. Given the negative net asset position, explicit confirmation should be sought from the director regarding the basis on which the accounts were prepared on a going concern basis, and whether any financial support commitment has been provided.

4. Business Viability and Revenue: With total assets of £687 and one employee, this appears to be a very small sole-practitioner operation in "other human health activities" (SIC 86900). Understanding the revenue model, client base, and whether the business generates sufficient cash flow to sustain operations is critical. No turnover figure is available from filed records.

5. Director's Other Interests: A full directorship history check for Uzmah Xxxxxxxname shown to subscribers should be conducted to identify any other active or dissolved companies, particularly any with insolvency events, which could indicate broader risk patterns.

6. Share Capital Adequacy: Share capital stands at just £1, providing no meaningful capital buffer. Any investor or creditor is exposed with virtually no equity cushion.

Names of the people mentioned are shown to subscribers. See subscription